and French TechBio startup Cure51 announced that Cure51 will deploy 10x Genomics’ Visium HD as part of its pioneering work to ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select ...

10x Genomics (NASDAQ:TXG) has built a reputation as a trailblazer in recent years, with cutting-edge single-cell and spatial technologies. The firm's Chromium, Visium and Xenium platforms have ...

10x Genomics' talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents and software that analyze biological systems at a resolution that ...

10x tools comprise three platforms: the original Chromium platform for analyzing loose single cells, which contributes the bulk of company revenue; the Visium platform for spatial analysis of ...

10x Genomics, Inc. (NASDAQ ... However, the adoption of new products like Visium CytAssist and Xenium 5K, along with positive reorder trends, indicate potential for growth. Despite a 1% decline ...